CONNEXIN 26 MUTATION DETECTION / EDTA BLOOD

image not found

NABL Cap Accredited 
The Connexin 26 Mutation Detection test identifies mutations in the GJB2 gene, a common genetic cause of congenital sensorineural hearing loss. Metropolis Healthcare performs this test using advanced molecular diagnostic techniques to ensure precise mutation detection. It helps confirm diagnosis, guide early intervention, and support genetic counselling for affected families. When interpreted with audiological evaluation, it provides valuable insight into the cause and management of hearing impairment.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,825.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: C0249

Frequently Asked Questions (FAQ's):

What does the Connexin 26 mutation test include at Metropolis Healthcare?
It includes molecular detection of mutations in the GJB2 (Connexin 26) gene.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular assays and strict quality standards.

Why is this test important?
It helps identify genetic causes of congenital or early-onset hearing loss.

Who should take this test at Metropolis Healthcare?
Children or adults with sensorineural hearing loss and families seeking genetic counselling.

Do I need special preparation before the test?
No special preparation is required; an EDTA blood sample is used.

Can this test detect all causes of hearing loss?
It detects known Connexin 26 mutations; other genetic causes may require additional testing.

How soon can I get results from Metropolis Healthcare?
Results are usually provided within the standard turnaround time for molecular testing.

How can results help clinicians at Metropolis Healthcare?
Results support diagnosis, early intervention planning, and informed family counselling.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab